Read more at The Wall Street Journal.
The FTC challenged hundreds of pharmaceutical patent listings in an effort to encourage generics, including for blockbusters such as Ozempic and Victoza.
Date: |
Sort by
Filter
Date
Items per page
-
Google is letting retailers include 3D images in AI-generated ads
Google is giving advertisers the ability to create immersive visuals in their online promotions.CNBC - Business - Google -
NFL schedule 2024: Complete list of games broadcast on CBS, including Eagles-Cowboys showdown in Week 10
A complete list of the NFL games on CBSCBS Sports - Sports - NFL -
A Moderna Patent Bailout Would Set a Dangerous Precedent
The Justice Department tries to use a wartime statute to make taxpayers pay for the company’s potential infringement liability.The Wall Street Journal - World -
Worship God the Father and Jesus Christ, Elder Cook encourages members in Australia
Yahoo News - World - Australia -
Moderna wins Covid jab patent dispute over Pfizer and BioNTech
Decision is a boon for the mRNA-vaccine maker in its legal fight to recoup pandemic profits from rivalsFinancial Times - Business - Covid -
GSK Sees Positive Trial Results For Potential Blockbuster Drug
GSK said two late-stage trials of an asthma drug that could have peak sales of almost $4 billion met their goals.The Wall Street Journal - World -
AltruBio Gathers Funds as Biotechs Aim for Next Blockbuster Anti-Inflammatory Therapy
Biotechnology startup AltruBio has secured fresh capital to develop a drug for ulcerative colitis as drugmakers compete to develop the next blockbuster therapy for this and other inflammatory diseases.The Wall Street Journal - World -
Potential blockbuster asthma drug met goals in trials, GSK says
GSK on Tuesday said two late-stage trials of an asthma drug that could have peak sales of more than £3 billion ($3.8 billion) met their goals.MarketWatch - Business -
Senators place blame for sky-high drug prices on abuse of the patent system
The drug industry’s top lobbying group faced fierce questioning at a Senate Judiciary Committee hearing on Tuesday that explored whether abuse of the patent system is responsible for keeping prescription drug prices sky-high in the United States.NBC News - Top stories -
I haven’t tried Ozempic but I know how it feels | Megan Nolan
Our desires are an essential part of who we are – as I discovered when I lost my appetite for six months. Mostly, walking down New York streets in spring sunshine is the cinematic, euphoric ideal of what it is to be alive. It’s the thing I looked ...The Guardian - World
More from The Wall Street Journal
-
Oil Falls Amid Demand Weakness, Fed Uncertainty
Oil prices fell in early Asian trade amid weakness in the physical market and uncertainty over the Fed’s rate-cut timeline.The Wall Street Journal - World - Federal Reserve -
Hong Kong Shares Open Flat; Tech Weakness Persists
Hong Kong’s benchmark Hang Seng Index was flat at 19225.26, as gains of auto and pharmaceutical stocks offset tech weakness.The Wall Street Journal - World - Hong Kong -
Pixar will lay off about 14% of its workforce as parent Disney seeks to cut costs and scale back the volume of content made exclusively for streaming.
Pixar will lay off about 14% of its workforce as parent Disney seeks to cut costs and scale back the volume of content made exclusively for streaming.The Wall Street Journal - World -
GSK's experimental drug for asthma met its goals in the latest trial, moving a treatment with potential annual peak sales of more than $3.81 billion closer to market.
GSK’s experimental drug for asthma met its goals in the latest trial, moving a treatment with potential annual peak sales of more than $3.81 billion closer to market.The Wall Street Journal - World -
Chinese EV maker XPeng forecast a rise in its second-quarter vehicle deliveries after its first-quarter net loss narrowed.
Chinese EV maker XPeng forecast a rise in its second-quarter vehicle deliveries after its first-quarter net loss narrowed.The Wall Street Journal - World